Primary Biliary Cholangitis

Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, leading to cholestasis, fibrosis, and eventually cirrhosis.

Definition

Primary biliary cholangitis (PBC) is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, leading to cholestasis, fibrosis, and eventually cirrhosis.

Epidemiology

  • Predominantly affects middle-aged women (female-to-male ratio ~9:1)
  • Peak incidence between 40–60 years
  • Prevalence higher in Northern Europe and North America
  • Rare in children and males
  • Often associated with other autoimmune disorders: Sjögren syndrome, thyroid disease, systemic sclerosis

Etiology

  • Autoimmune destruction of small intrahepatic bile ducts
  • Genetic predisposition: HLA-DR8, HLA-DRB1 alleles
  • Environmental triggers suspected: infections, xenobiotics
  • Association with other autoimmune diseases
  • No known infectious or viral cause

Pathophysiology

  • Immune-mediated destruction of small intrahepatic bile ducts
  • Cholestasis leads to accumulation of bile acids, causing hepatocyte injury
  • Progressive fibrosis develops, leading to cirrhosis and portal hypertension
  • Chronic inflammation triggers autoimmune responses (AMA antibodies against PDC-E2 enzyme)
  • Eventually leads to liver failure if untreated
Messenger Icon